Home Healthcare IT Oncology Biosimilar Market Size, Top Share, Demand | Industry Report, 2034

Oncology Biosimilar Market Size & Outlook, 2026-2034

The global market for oncology biosimilars is estimated at USD 8 billion in 2025 and is projected to grow from USD 9.48 billion in 2026 to USD 36.90 billion in 2034, exhibiting a CAGR of 18.5% during the forecast period (2025–2034).
Oncology Biosimilar Market Size, Share & Trends Analysis Report By Product Type (Monoclonal Antibodies (mAbs), Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF), Immunomodulators), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Blood Cancer / Hematological Cancers, Other), By Route of Administration (Intravenous (IV), Subcutaneous (SC), Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRHI40DR
Last Updated : Sep, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. Oncology Biosimilar Market, By Product Type (2022-2034)
    1. Monoclonal Antibodies (mAbs)
    2. Hematopoietic Agents
    3. Granulocyte Colony-Stimulating Factor (G-CSF)
    4. Immunomodulators
  2. Oncology Biosimilar Market, By Cancer Type (2022-2034)
    1. Breast Cancer
    2. Lung Cancer
    3. Colorectal Cancer
    4. Cervical Cancer
    5. Blood Cancer / Hematological Cancers
    6. Other types (e.g., kidney, stomach, brain cancers)
  3. Oncology Biosimilar Market, By Route of Administration (2022-2034)
    1. Intravenous (IV)
    2. Subcutaneous (SC)
    3. Others
  4. Oncology Biosimilar Market, By Distribution Channel (2022-2034)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    4. Others
    1. North America
      1. North America Oncology Biosimilar Market, By Product Type
        1. Monoclonal Antibodies (mAbs)
          1. Hematopoietic Agents
            1. Granulocyte Colony-Stimulating Factor (G-CSF)
              1. Immunomodulators
              2. North America Oncology Biosimilar Market, By Cancer Type
                1. Breast Cancer
                  1. Lung Cancer
                    1. Colorectal Cancer
                      1. Cervical Cancer
                        1. Blood Cancer / Hematological Cancers
                          1. Other types (e.g., kidney, stomach, brain cancers)
                          2. North America Oncology Biosimilar Market, By Route of Administration
                            1. Intravenous (IV)
                              1. Subcutaneous (SC)
                                1. Others
                                2. North America Oncology Biosimilar Market, By Distribution Channel
                                  1. Hospital Pharmacies
                                    1. Retail Pharmacies
                                      1. Online Pharmacies
                                        1. Others
                                        2. U.S.
                                          1. U.S. Oncology Biosimilar Market, By Product Type
                                            1. Monoclonal Antibodies (mAbs)
                                              1. Hematopoietic Agents
                                                1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                  1. Immunomodulators
                                                  2. U.S. Oncology Biosimilar Market, By Cancer Type
                                                    1. Breast Cancer
                                                      1. Lung Cancer
                                                        1. Colorectal Cancer
                                                          1. Cervical Cancer
                                                            1. Blood Cancer / Hematological Cancers
                                                              1. Other types (e.g., kidney, stomach, brain cancers)
                                                              2. U.S. Oncology Biosimilar Market, By Route of Administration
                                                                1. Intravenous (IV)
                                                                  1. Subcutaneous (SC)
                                                                    1. Others
                                                                    2. U.S. Oncology Biosimilar Market, By Distribution Channel
                                                                      1. Hospital Pharmacies
                                                                        1. Retail Pharmacies
                                                                          1. Online Pharmacies
                                                                            1. Others
                                                                          2. Canada
                                                                        2. Europe
                                                                          1. Europe Oncology Biosimilar Market, By Product Type
                                                                            1. Monoclonal Antibodies (mAbs)
                                                                              1. Hematopoietic Agents
                                                                                1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                  1. Immunomodulators
                                                                                  2. Europe Oncology Biosimilar Market, By Cancer Type
                                                                                    1. Breast Cancer
                                                                                      1. Lung Cancer
                                                                                        1. Colorectal Cancer
                                                                                          1. Cervical Cancer
                                                                                            1. Blood Cancer / Hematological Cancers
                                                                                              1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                              2. Europe Oncology Biosimilar Market, By Route of Administration
                                                                                                1. Intravenous (IV)
                                                                                                  1. Subcutaneous (SC)
                                                                                                    1. Others
                                                                                                    2. Europe Oncology Biosimilar Market, By Distribution Channel
                                                                                                      1. Hospital Pharmacies
                                                                                                        1. Retail Pharmacies
                                                                                                          1. Online Pharmacies
                                                                                                            1. Others
                                                                                                            2. U.K.
                                                                                                              1. U.K. Oncology Biosimilar Market, By Product Type
                                                                                                                1. Monoclonal Antibodies (mAbs)
                                                                                                                  1. Hematopoietic Agents
                                                                                                                    1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                                                      1. Immunomodulators
                                                                                                                      2. U.K. Oncology Biosimilar Market, By Cancer Type
                                                                                                                        1. Breast Cancer
                                                                                                                          1. Lung Cancer
                                                                                                                            1. Colorectal Cancer
                                                                                                                              1. Cervical Cancer
                                                                                                                                1. Blood Cancer / Hematological Cancers
                                                                                                                                  1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                                                                  2. U.K. Oncology Biosimilar Market, By Route of Administration
                                                                                                                                    1. Intravenous (IV)
                                                                                                                                      1. Subcutaneous (SC)
                                                                                                                                        1. Others
                                                                                                                                        2. U.K. Oncology Biosimilar Market, By Distribution Channel
                                                                                                                                          1. Hospital Pharmacies
                                                                                                                                            1. Retail Pharmacies
                                                                                                                                              1. Online Pharmacies
                                                                                                                                                1. Others
                                                                                                                                              2. Germany
                                                                                                                                              3. France
                                                                                                                                              4. Spain
                                                                                                                                              5. Italy
                                                                                                                                              6. Russia
                                                                                                                                              7. Nordic
                                                                                                                                              8. Benelux
                                                                                                                                              9. Rest of Europe
                                                                                                                                            2. APAC
                                                                                                                                              1. APAC Oncology Biosimilar Market, By Product Type
                                                                                                                                                1. Monoclonal Antibodies (mAbs)
                                                                                                                                                  1. Hematopoietic Agents
                                                                                                                                                    1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                                                                                      1. Immunomodulators
                                                                                                                                                      2. APAC Oncology Biosimilar Market, By Cancer Type
                                                                                                                                                        1. Breast Cancer
                                                                                                                                                          1. Lung Cancer
                                                                                                                                                            1. Colorectal Cancer
                                                                                                                                                              1. Cervical Cancer
                                                                                                                                                                1. Blood Cancer / Hematological Cancers
                                                                                                                                                                  1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                                                                                                  2. APAC Oncology Biosimilar Market, By Route of Administration
                                                                                                                                                                    1. Intravenous (IV)
                                                                                                                                                                      1. Subcutaneous (SC)
                                                                                                                                                                        1. Others
                                                                                                                                                                        2. APAC Oncology Biosimilar Market, By Distribution Channel
                                                                                                                                                                          1. Hospital Pharmacies
                                                                                                                                                                            1. Retail Pharmacies
                                                                                                                                                                              1. Online Pharmacies
                                                                                                                                                                                1. Others
                                                                                                                                                                                2. China
                                                                                                                                                                                  1. China Oncology Biosimilar Market, By Product Type
                                                                                                                                                                                    1. Monoclonal Antibodies (mAbs)
                                                                                                                                                                                      1. Hematopoietic Agents
                                                                                                                                                                                        1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                                          2. China Oncology Biosimilar Market, By Cancer Type
                                                                                                                                                                                            1. Breast Cancer
                                                                                                                                                                                              1. Lung Cancer
                                                                                                                                                                                                1. Colorectal Cancer
                                                                                                                                                                                                  1. Cervical Cancer
                                                                                                                                                                                                    1. Blood Cancer / Hematological Cancers
                                                                                                                                                                                                      1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                                                                                                                                      2. China Oncology Biosimilar Market, By Route of Administration
                                                                                                                                                                                                        1. Intravenous (IV)
                                                                                                                                                                                                          1. Subcutaneous (SC)
                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                            2. China Oncology Biosimilar Market, By Distribution Channel
                                                                                                                                                                                                              1. Hospital Pharmacies
                                                                                                                                                                                                                1. Retail Pharmacies
                                                                                                                                                                                                                  1. Online Pharmacies
                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                  2. Korea
                                                                                                                                                                                                                  3. Japan
                                                                                                                                                                                                                  4. India
                                                                                                                                                                                                                  5. Australia
                                                                                                                                                                                                                  6. Taiwan
                                                                                                                                                                                                                  7. South East Asia
                                                                                                                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                                                                                                                2. Middle East and Africa
                                                                                                                                                                                                                  1. Middle East and Africa Oncology Biosimilar Market, By Product Type
                                                                                                                                                                                                                    1. Monoclonal Antibodies (mAbs)
                                                                                                                                                                                                                      1. Hematopoietic Agents
                                                                                                                                                                                                                        1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                                                                                                                                                          1. Immunomodulators
                                                                                                                                                                                                                          2. Middle East and Africa Oncology Biosimilar Market, By Cancer Type
                                                                                                                                                                                                                            1. Breast Cancer
                                                                                                                                                                                                                              1. Lung Cancer
                                                                                                                                                                                                                                1. Colorectal Cancer
                                                                                                                                                                                                                                  1. Cervical Cancer
                                                                                                                                                                                                                                    1. Blood Cancer / Hematological Cancers
                                                                                                                                                                                                                                      1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                                                                                                                                                                      2. Middle East and Africa Oncology Biosimilar Market, By Route of Administration
                                                                                                                                                                                                                                        1. Intravenous (IV)
                                                                                                                                                                                                                                          1. Subcutaneous (SC)
                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                            2. Middle East and Africa Oncology Biosimilar Market, By Distribution Channel
                                                                                                                                                                                                                                              1. Hospital Pharmacies
                                                                                                                                                                                                                                                1. Retail Pharmacies
                                                                                                                                                                                                                                                  1. Online Pharmacies
                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                    2. UAE
                                                                                                                                                                                                                                                      1. UAE Oncology Biosimilar Market, By Product Type
                                                                                                                                                                                                                                                        1. Monoclonal Antibodies (mAbs)
                                                                                                                                                                                                                                                          1. Hematopoietic Agents
                                                                                                                                                                                                                                                            1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                                                                                                                                                                                              1. Immunomodulators
                                                                                                                                                                                                                                                              2. UAE Oncology Biosimilar Market, By Cancer Type
                                                                                                                                                                                                                                                                1. Breast Cancer
                                                                                                                                                                                                                                                                  1. Lung Cancer
                                                                                                                                                                                                                                                                    1. Colorectal Cancer
                                                                                                                                                                                                                                                                      1. Cervical Cancer
                                                                                                                                                                                                                                                                        1. Blood Cancer / Hematological Cancers
                                                                                                                                                                                                                                                                          1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                                                                                                                                                                                                          2. UAE Oncology Biosimilar Market, By Route of Administration
                                                                                                                                                                                                                                                                            1. Intravenous (IV)
                                                                                                                                                                                                                                                                              1. Subcutaneous (SC)
                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                2. UAE Oncology Biosimilar Market, By Distribution Channel
                                                                                                                                                                                                                                                                                  1. Hospital Pharmacies
                                                                                                                                                                                                                                                                                    1. Retail Pharmacies
                                                                                                                                                                                                                                                                                      1. Online Pharmacies
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                      1. LATAM Oncology Biosimilar Market, By Product Type
                                                                                                                                                                                                                                                                                        1. Monoclonal Antibodies (mAbs)
                                                                                                                                                                                                                                                                                          1. Hematopoietic Agents
                                                                                                                                                                                                                                                                                            1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                                                                                                                                                                                                                              1. Immunomodulators
                                                                                                                                                                                                                                                                                              2. LATAM Oncology Biosimilar Market, By Cancer Type
                                                                                                                                                                                                                                                                                                1. Breast Cancer
                                                                                                                                                                                                                                                                                                  1. Lung Cancer
                                                                                                                                                                                                                                                                                                    1. Colorectal Cancer
                                                                                                                                                                                                                                                                                                      1. Cervical Cancer
                                                                                                                                                                                                                                                                                                        1. Blood Cancer / Hematological Cancers
                                                                                                                                                                                                                                                                                                          1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                                                                                                                                                                                                                                          2. LATAM Oncology Biosimilar Market, By Route of Administration
                                                                                                                                                                                                                                                                                                            1. Intravenous (IV)
                                                                                                                                                                                                                                                                                                              1. Subcutaneous (SC)
                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                2. LATAM Oncology Biosimilar Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                  1. Hospital Pharmacies
                                                                                                                                                                                                                                                                                                                    1. Retail Pharmacies
                                                                                                                                                                                                                                                                                                                      1. Online Pharmacies
                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                        2. Brazil
                                                                                                                                                                                                                                                                                                                          1. Brazil Oncology Biosimilar Market, By Product Type
                                                                                                                                                                                                                                                                                                                            1. Monoclonal Antibodies (mAbs)
                                                                                                                                                                                                                                                                                                                              1. Hematopoietic Agents
                                                                                                                                                                                                                                                                                                                                1. Granulocyte Colony-Stimulating Factor (G-CSF)
                                                                                                                                                                                                                                                                                                                                  1. Immunomodulators
                                                                                                                                                                                                                                                                                                                                  2. Brazil Oncology Biosimilar Market, By Cancer Type
                                                                                                                                                                                                                                                                                                                                    1. Breast Cancer
                                                                                                                                                                                                                                                                                                                                      1. Lung Cancer
                                                                                                                                                                                                                                                                                                                                        1. Colorectal Cancer
                                                                                                                                                                                                                                                                                                                                          1. Cervical Cancer
                                                                                                                                                                                                                                                                                                                                            1. Blood Cancer / Hematological Cancers
                                                                                                                                                                                                                                                                                                                                              1. Other types (e.g., kidney, stomach, brain cancers)
                                                                                                                                                                                                                                                                                                                                              2. Brazil Oncology Biosimilar Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                                1. Intravenous (IV)
                                                                                                                                                                                                                                                                                                                                                  1. Subcutaneous (SC)
                                                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                                                    2. Brazil Oncology Biosimilar Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                                                      1. Hospital Pharmacies
                                                                                                                                                                                                                                                                                                                                                        1. Retail Pharmacies
                                                                                                                                                                                                                                                                                                                                                          1. Online Pharmacies
                                                                                                                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                                                                                                                                                                                          4. Chile
                                                                                                                                                                                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                      Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                                                                                      Get This Report

                                                                                                                                                                                                                                                                                                                                                      Download Free Sample

                                                                                                                                                                                                                                                                                                                                                      Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                                                                                      The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                                                                                      Our Clients:

                                                                                                                                                                                                                                                                                                                                                      LG Electronics
                                                                                                                                                                                                                                                                                                                                                      AMCAD Engineering
                                                                                                                                                                                                                                                                                                                                                      KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                                                                      Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                                                                      Voith Group
                                                                                                                                                                                                                                                                                                                                                      International Paper
                                                                                                                                                                                                                                                                                                                                                      Hansol Paper
                                                                                                                                                                                                                                                                                                                                                      Whirlpool Corporation
                                                                                                                                                                                                                                                                                                                                                      Sony
                                                                                                                                                                                                                                                                                                                                                      Samsung Electronics
                                                                                                                                                                                                                                                                                                                                                      Qualcomm
                                                                                                                                                                                                                                                                                                                                                      Google
                                                                                                                                                                                                                                                                                                                                                      Fiserv
                                                                                                                                                                                                                                                                                                                                                      Veto-Pharma
                                                                                                                                                                                                                                                                                                                                                      Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                                                                      Merck
                                                                                                                                                                                                                                                                                                                                                      Argon Medical Devices
                                                                                                                                                                                                                                                                                                                                                      Abbott
                                                                                                                                                                                                                                                                                                                                                      Ajinomoto
                                                                                                                                                                                                                                                                                                                                                      Denon
                                                                                                                                                                                                                                                                                                                                                      Doosan
                                                                                                                                                                                                                                                                                                                                                      Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                                                                      LG Chemicals
                                                                                                                                                                                                                                                                                                                                                      LCY chemical group
                                                                                                                                                                                                                                                                                                                                                      Bayer
                                                                                                                                                                                                                                                                                                                                                      Airrane
                                                                                                                                                                                                                                                                                                                                                      BASF
                                                                                                                                                                                                                                                                                                                                                      Toyota Industries
                                                                                                                                                                                                                                                                                                                                                      Nissan Motors
                                                                                                                                                                                                                                                                                                                                                      Neenah
                                                                                                                                                                                                                                                                                                                                                      Mitsubishi
                                                                                                                                                                                                                                                                                                                                                      Hyundai Motor Company

                                                                                                                                                                                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                                                                                                                                                                                      Address:
                                                                                                                                                                                                                                                                                                                                                      Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                                                                                      Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                                                                                      Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                                                                                      Contact Us:
                                                                                                                                                                                                                                                                                                                                                      +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                                                                      +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                                                                      +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                                                                      sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                                                                      Quick Links
                                                                                                                                                                                                                                                                                                                                                      Help
                                                                                                                                                                                                                                                                                                                                                      Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                                                                      DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                                                                      Secure Payments:
                                                                                                                                                                                                                                                                                                                                                      Follow Us:
                                                                                                                                                                                                                                                                                                                                                      www.straitsresearch.com © Copyright . All rights Reserved.